Texas Biomed Professor Luis Martinez-Sobrido, PhD, will participate in three of the nine Antiviral Drug Discovery (AViDD) Centers for Pathogens of Pandemic Concern announced by NIH this spring.
Texas Biomed researchers developed reporter viruses to express different colors for different variants of SARS-CoV-2. This enables them to easily see if treatments, vaccines or neutralizing antibodies work against multiple variants at the same time.